Oruka Therapeutics (ORKA) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.00% |
| Dec 31, 2025 | 124.56% |
| Sep 30, 2025 | 125.02% |
| Jun 30, 2025 | 96.98% |
| Mar 31, 2025 | 96.68% |
| Dec 31, 2024 | 95.64% |
| Sep 30, 2024 | 82.20% |
| Jun 30, 2024 | -35.24% |
| Mar 31, 2024 | -28.20% |
| Dec 31, 2023 | -7.33% |
| Sep 30, 2023 | -9.04% |
| Jun 30, 2023 | 56.15% |
| Mar 31, 2023 | 85.93% |
| Dec 31, 2022 | 76.26% |
| Sep 30, 2022 | 69.34% |
| Jun 30, 2022 | 69.77% |
| Mar 31, 2022 | 87.11% |
| Dec 31, 2021 | 103.78% |
| Sep 30, 2021 | 96.47% |
| Jun 30, 2021 | 89.48% |
| Mar 31, 2021 | 81.33% |
| Dec 31, 2020 | 65.43% |
| Sep 30, 2020 | 52.05% |
| Jun 30, 2020 | -11.26% |
| Mar 31, 2020 | -29.55% |
| Dec 31, 2019 | -30.01% |
| Sep 30, 2019 | -30.74% |
| Jun 30, 2019 | -33.25% |
| Mar 31, 2019 | -40.41% |
| Dec 31, 2018 | -45.89% |
| Sep 30, 2018 | -43.37% |
| Jun 30, 2018 | -40.98% |
| Mar 31, 2018 | -3.04% |
| Dec 31, 2017 | -11.34% |
| Sep 30, 2017 | -5.85% |
| Jun 30, 2017 | -8.61% |
| Mar 31, 2017 | -5.74% |
| Dec 31, 2016 | 12.52% |
| Sep 30, 2016 | 12.97% |
| Jun 30, 2016 | 15.53% |
| Mar 31, 2016 | 118.59% |
| Dec 31, 2015 | 135.71% |
| Sep 30, 2015 | 134.76% |
| Jun 30, 2015 | 137.00% |
| Mar 31, 2015 | 40.68% |
| Dec 31, 2014 | 37.01% |
| Sep 30, 2014 | 44.23% |
| Jun 30, 2014 | 36.81% |
| Dec 31, 2013 | 32.02% |